Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
J Am Soc Cytopathol. 2022 Mar-Apr;11(2):87-93. doi: 10.1016/j.jasc.2021.12.001. Epub 2021 Dec 15.
Patient safety and quality improvement initiatives are integral parts of every cytopathology laboratory. The need to revisit our approaches to patient safety are essential in light of the expanding test menu, ancillary studies, comprehensive diagnostic reports, and emergence of new technologies for augmenting cytologic diagnosis. Our interview with Drs. Yael Heher, Adam Seegmiller, and Paul VanderLaan explores recent developments that have shaped their perspectives in patient safety, test usage, and laboratory quality. The practical strategies presented provide tools for enhanced patient safety and improved outcomes in a new era of ancillary and molecular testing and standardized reporting in the cytopathology laboratory.
患者安全和质量改进举措是每个细胞病理学实验室不可或缺的组成部分。鉴于不断扩大的测试菜单、辅助研究、全面的诊断报告以及增强细胞学诊断的新技术的出现，我们有必要重新审视我们的患者安全方法。我们对 Yael Heher、Adam Seegmiller 和 Paul VanderLaan 医生的采访探讨了最近的发展情况，这些发展情况影响了他们在患者安全、测试使用和实验室质量方面的观点。所提出的实用策略为在细胞病理学实验室中辅助和分子测试以及标准化报告的新时代提供了增强患者安全性和改善结果的工具。
